CVE-2018-14781 Explained : Impact and Mitigation
Learn about CVE-2018-14781 affecting Medtronic insulin pumps, allowing unauthorized insulin delivery. Find mitigation steps and long-term security practices.
Medtronic insulin pump models are vulnerable to a capture-replay attack, allowing unauthorized insulin delivery.
Understanding CVE-2018-14781
What is CVE-2018-14781?
The Medtronic MMT 508 MiniMed insulin pump and other models are susceptible to a capture-replay attack, enabling attackers to initiate insulin delivery.
The Impact of CVE-2018-14781
The vulnerability in Medtronic insulin pumps can lead to unauthorized insulin administration, posing serious health risks to patients.
Technical Details of CVE-2018-14781
Vulnerability Description
The vulnerability allows attackers to capture wireless transmissions between the pump and remote controller, replaying them to trigger insulin delivery.
Affected Systems and Versions
- Medtronic MMT 508 MiniMed insulin pump
- MMT - 722 Paradigm REAL-TIME
- MMT - 723 Paradigm Revel
- MMT - 723K Paradigm Revel
- MMT - 751 MiniMed 530G
Exploitation Mechanism
- Attacker captures wireless transmissions between the remote controller and the pump
- Replay captured transmissions to initiate insulin delivery
Mitigation and Prevention
Immediate Steps to Take
- Disable